Airway hyper-responsiveness to adenosine 5'-monophosphate in preschool-age children with asthma

Arzu Bakirtas1, Ipek Turktas

  • 1Gazi University, Faculty of Medicine, Department of Pediatric Allergy and Asthma, Ankara, Turkey. arzub@gazi.edu.tr

Insights

Peripheral blood eosinophilia predicts airway hyper-responsiveness to adenosine 5'-monophosphate (AMP) in young asthmatic children. This contrasts with atopy markers, offering a key insight for predicting AMP responsiveness in pediatric asthma.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Respiratory Medicine

Background:

  • Airway hyper-responsiveness (AHR) to adenosine 5 extapostrophe-monophosphate (AMP) is linked to airway inflammation in asthma.
  • Not all asthmatic patients exhibit AMP responsiveness, necessitating identification of predictive factors.

Purpose of the Study:

  • To investigate predictive factors for AHR to AMP in preschool-aged children with asthma.
  • To assess the relationship between AMP responsiveness and atopy, immunoglobulin E (IgE) levels, and eosinophilia.

Main Methods:

  • Retrospective analysis of 63 asthmatic children (3-6 years old) challenged with AMP.
  • Evaluated skin-prick tests, serum IgE, peripheral blood eosinophil percentage, and bronchial challenges with methacholine (MCH) and AMP.

Main Results:

  • 46% of children showed AHR to AMP; 93.7% showed AHR to MCH.
  • Peripheral blood eosinophilia was the sole significant predictor of AMP responsiveness (OR: 5.14, p=0.025).
  • AMP-responsive children had higher median serum IgE levels and more frequent peripheral blood eosinophilia compared to non-responsive children.

Conclusions:

  • Peripheral blood eosinophilia can predict AMP responsiveness in preschool-aged asthmatic children.
  • Atopy markers are not reliable predictors of AMP responsiveness in this age group.
  • Findings suggest eosinophil count is a valuable clinical indicator for predicting AMP AHR in young asthmatics.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...